Sanjay Keni, MD
Otolaryngology/Facial Plastic Surgery · Palos Heights, ILNPI 1720273378
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Optinose US, Inc. accounts for 74.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $150 and has fallen 65.5% since, to $52 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in IL, where the typical reported total is $914.
Across 35 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$438
- Intersect ENT, Inc.$52
- Stryker$51
- Baxter Healthcare$26
- Hikma Pharmaceuticals USA$19
What the payments were for
- Food & beverage$587100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 28 | $438 |
| Intersect ENT, Inc. | 2 | $52 |
| Stryker | 3 | $51 |
| Baxter Healthcare | 1 | $26 |
| Hikma Pharmaceuticals USA | 1 | $19 |
How this compares
$587 in reported general payments places this provider in the 35th percentile of 23 otolaryngology/facial plastic surgery providers in Illinois.
See all otolaryngology/facial plastic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 19 | $4,673 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 18 | $2,416 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 50 | $2,172 |
| Fluocinolone Acetonide Oil | 48 | $1,718 |
| Ipratropium Bromide | 57 | $1,302 |
| Azelastine Hcl | 50 | $1,016 |
| Methylprednisolone | 102 | $461 |
| Fluticasone Propionate | 35 | $394 |
| Mometasone Furoate | 30 | $370 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 46 | $321 |
| Meclizine Hcl | 34 | $251 |
| Levothyroxine Sodium | 13 | $250 |
| Ofloxacin | 11 | $223 |
| Azithromycin | 44 | $181 |
| Mupirocin | 23 | $122 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Palos Heights
- Ryan VaughnSchaumburg$154K
- Bryan RubachAurora$19K
- Michael LaylandPark Ridge$10K
- Garrett NiMount Carmel$5K
- Gary ShawCanton$3K
- Gary WiesmanChicago$2K
- Michael EggerstedtChicago$2K
- Terry DonatSterling$2K
- Mir JoffreySchaumburg$2K
- Xinyan HuangSpringfield$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.